换一批
换一批TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma.
作者：
Grégoire,Gessain [1]
;
Ahmed-Amine,Anzali [2]
;
Marvin,Lerousseau [3]
;
Kevin,Mulder [2]
;
Mathilde,Bied [2]
;
Anne,Auperin [4]
;
Daniel,Stockholm [5]
;
Nicolas,Signolle [6]
;
Farah,Sassi [2]
;
Maria Eugenia,Marques Da Costa [7]
;
Antonin,Marchais [7]
;
Alexandre,Sayadi [8]
;
Daniela,Weidner [9]
;
Stefan,Uderhardt [9]
;
Quentin,Blampey [10]
;
Sumanth Reddy,Nakkireddy [11]
;
Sophie,Broutin [12]
;
Charles-Antoine,Dutertre [2]
;
Pierre,Busson [13]
;
Thomas,Walter [3]
;
Alix,Marhic [14]
;
Antoine,Moya-Plana [14]
;
Johanne,Guerlain [14]
;
Ingrid,Breuskin [14]
;
Odile,Casiraghi [15]
;
Philippe,Gorphe [14]
;
Marion,Classe [16]
;
Jean-Yves,Scoazec [17]
;
Camille,Blériot [18]
;
Florent,Ginhoux [19]
作者单位：
INSERM U1015, Gustave Roussy Cancer Campus, Bâtiment de Médecine Moléculaire, Villejuif, France.;Université Paris Cité, Faculté de Santé, Paris, France.
[1]
INSERM U1015, Gustave Roussy Cancer Campus, Bâtiment de Médecine Moléculaire, Villejuif, France.
[2]
Center for computational biology (CBIO), Mines Paris, PSL University, Paris, France.;Institut Curie, PSL University, Paris, France.;INSERM, U900, Paris, France.
[3]
Biostatistics and Epidemiology Office, Gustave Roussy, Oncostat INSERM 1018, Labelled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France.
[4]
PSL Research University, EPHE, Paris, France.;Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
[5]
Experimental and Translational Pathology Platform, AMMICa, INSERM US23/UAR3655, Gustave Roussy, Villejuif, France.
[6]
INSERM U1015, Gustave Roussy Cancer Campus, Bâtiment de Médecine Moléculaire, Villejuif, France.;Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay Villejuif, France.
[7]
Université Paris Cité, Faculté de Santé, Paris, France.
[8]
Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.;Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.;Exploratory Research Unit, Optical Imaging Centre Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
[9]
Paris-Saclay University, CentraleSupélec, laboratory of Mathematics and Computer Science (MICS), Gif-sur-Yvette, France.;Paris-Saclay University, Gustave Roussy, Villejuif, France.
[10]
Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Jacksonville, Florida.
[11]
Department of Pharmacology, Institut Gustave Roussy, Villejuif, France.
[12]
CNRS, UMR 9018, Gustave Roussy and Université Paris-Saclay, 39, rue Camille Desmoulins, Villejuif, France.
[13]
Department of Head and Neck Oncology, Gustave Roussy Cancer Campus Villejuif, France.
[14]
Department of Pathology, University Paris-Saclay, Gustave Roussy Cancer Center, Villejuif, France.
[15]
Department of Pathology, University Paris-Saclay, Gustave Roussy Cancer Center, Villejuif, France.;Precision Medicine and Computational Biology, Sanofi Research France, Paris, France.
[16]
Experimental and Translational Pathology Platform, AMMICa, INSERM US23/UAR3655, Gustave Roussy, Villejuif, France.;Department of Pathology, University Paris-Saclay, Gustave Roussy Cancer Center, Villejuif, France.
[17]
INSERM U1015, Gustave Roussy Cancer Campus, Bâtiment de Médecine Moléculaire, Villejuif, France.;CNRS, UMR 9018, Gustave Roussy and Université Paris-Saclay, 39, rue Camille Desmoulins, Villejuif, France.;Institut Necker Enfants Malades (INEM), CNRS UMR 8253, INSERM U1151, Paris, France.
[18]
INSERM U1015, Gustave Roussy Cancer Campus, Bâtiment de Médecine Moléculaire, Villejuif, France.;Paris-Saclay University, Gustave Roussy, Villejuif, France.;Department of Immunology and Microbiology, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.;Singapore Immunology Network (SIgN), A*STAR, Singapore, Singapore.;Translational Immunology Institute, SingHealth/Duke-NUS Academic Medical Centre, Singapore, Singapore.
[19]
主题词
人类(Humans);膜糖蛋白类(Membrane Glycoproteins);预后(Prognosis);受体, 免疫(Receptors, Immunologic);巨噬细胞(Macrophages);头颈部肿瘤(Head and Neck Neoplasms);巨细胞(Giant Cells)
DOI
10.1158/2159-8290.CD-24-0018
PMID
39270324
发布时间
2024-12-04
- 浏览0
Cancer discovery
Cancer discovery
2352-2366页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
